A case series of low dose bevacizumab and chemotherapy in heavily pretreated patients with epithelial ovarian cancer

被引：0
|
作者：
Carlotta Defferrari
Sara Campora
Mauro D'Amico
Arnoldo Piccardo
Ennio Biscaldi
Daniela Rosselli
Ambra Pasa
Matteo Puntoni
Alberto Gozza
Alessandra Gennari
Silvia Zanardi
Rita Lionetto
Michela Bandelloni
Andrea DeCensi
机构：
[1] E.O. Ospedali Galliera,Unit of Medical Oncology
[2] E.O. Ospedali Galliera,Nuclear Medicine
[3] E.O. Ospedali Galliera,Radiology
[4] E.O. Ospedali Galliera,Gynecology
[5] E.O. Ospedali Galliera,Scientific Direction
[6] E.O. Ospedali Galliera,Health Direction
[7] E.O. Ospedali Galliera,Pharmacy
来源：
Journal of Ovarian Research | / 5卷
关键词：
Bevacizumab; Standardize Uptake Value; Epithelial Ovarian Cancer; Diabetic Macular Edema; Weekly Paclitaxel;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] A case series of low dose bevacizumab and chemotherapy in heavily pretreated patients with epithelial ovarian cancer
    Carlotta, Defferrari
    Sara, Campora
    Mauro, D'Amico
    Arnoldo, Piccardo
    Ennio, Biscaldi
    Daniela, Rosselli
    Ambra, Pasa
    Matteo, Puntoni
    Alberto, Gozza
    Alessandra, Gennari
    Silvia, Zanardi
    Rita, Lionetto
    Michela, Bandelloni
    Andrea, DeCensi
    JOURNAL OF OVARIAN RESEARCH, 2012, 5
  • [2] Bevacizumab plus Low-Dose Metronomic Oral Cyclophosphamide in Heavily Pretreated Patients with Recurrent Ovarian Cancer
    Sanchez-Munoz, Alfonso
    Mendiola, Cesar
    Perez-Ruiz, Elisabeth
    Rodriguez-Sanchez, Cesar A.
    Miguel Jurado, Jose
    Alonso-Carrion, Lorenzo
    Ghanem, Ismael
    de Velasco, Guillermo
    Quero-Blanco, Cristina
    Alba, Emilio
    ONCOLOGY, 2010, 79 (1-2) : 98 - 104
  • [3] Intra-arterial hepatic chemotherapy in heavily pretreated patients with epithelial ovarian cancer
    Mambrini, A
    Caudana, R
    Zamagni, D
    Rabbi, C
    Del Freo, A
    Sanguinetti, F
    Fiorentini, G
    Cantore, M
    ANNALS OF ONCOLOGY, 2005, 16 (02) : 334 - 335
  • [4] Bevacizumab alone or with chemotherapy in highly pretreated, relapsed, epithelial ovarian cancer patients.
    Ojeda, B.
    Casado, A.
    Tibau, A.
    Redondo, A.
    Beltran, M.
    Garcia-Martinez, E.
    Santaballa, A.
    Pardo, B.
    Lianes, P.
    Bover, I.
    Garcia-Donas, J.
    Churruca, C. M.
    Cueva, J. F.
    Sanchez-Heras, A. B.
    Gordon-Santiago, M. M.
    Arcusa Lanza, A.
    Lopez-Rodriguez, A.
    Caballero, C.
    Ortega-Izquierdo, M. E.
    Gonzalez-Martin, A.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [5] Bevacizumab plus cyclophosphamide in heavily pretreated patients with recurrent ovarian cancer
    Chura, Justin C.
    Van Iseghem, Kelin
    Downs, Levi S., Jr.
    Carson, Linda F.
    Judson, Patricia L.
    GYNECOLOGIC ONCOLOGY, 2007, 107 (02) : 326 - 330
  • [6] Bevacizumab plus low-dose metronomic oral cyclophosphamide in heavily pretreated recurrent ovarian cancer.
    Sanchez-Munoz, A.
    Mendiola, C.
    Rodriguez, C. A.
    Perez-Ruiz, E.
    Jurado, J. M.
    Alonso-Carrion, L.
    Ghanem, I.
    Deelasco, G.
    Quero Blanco, C.
    Alba, E.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [7] Feasibility of bevacizumab (BEV) plus chemotherapy in heavily pretreated ovarian cancer (OC) patients (pts): A retrospective study
    Asmane, I.
    Guastalla, J. P.
    Meeus, P.
    Moullet, I.
    Ardisson, P.
    Vincent, L.
    Coeffic, D.
    Dufresne, A.
    Bajard, A.
    Ray-Coquard, I. L.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [8] Pegylated liposomal doxorubicin in heavily pretreated epithelial ovarian cancer patients
    Gorumlu, G.
    Kucukzeybek, Y.
    Kemal-Gul, M.
    Karaca, B.
    Cosan-Terek, M.
    Karabulut, B.
    Sanli, U. A.
    Akman, L.
    Ozsaran, A.
    Dikmen, Y.
    Uslu, R.
    JOURNAL OF BUON, 2008, 13 (03): : 349 - 352
  • [9] Striking response with bevacizumab and chemotherapy in a woman with heavily pretreated breast cancer: a case presentation
    Prassl, K.
    Sahanic, A.
    Reicher, B.
    Denz, H.
    Freund, M.
    Fiegl, M.
    MEMO-MAGAZINE OF EUROPEAN MEDICAL ONCOLOGY, 2008, 1 (03) : 149 - 151
  • [10] Striking response with bevacizumab and chemotherapy in a woman with heavily pretreated breast cancer: a case presentation
    K. Prassl
    A. Sahanic
    B. Reicher
    H. Denz
    M. Freund
    M. Fiegl
    memo - Magazine of European Medical Oncology, 2008, 1 (3) : 149 - 151
12345